SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ---------------------------------- FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 28, 1999 HUMAN PHEROMONE SCIENCES, INC. - -------------------------------------------------------------------------------- (Exact name of Registrant as specified in its charter) CALIFORNIA 0-23544 94-3107202 - -------------------------------------------------------------------------------- (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 4034 CLIPPER COURT, FREMONT, CALIFORNIA 94538 - -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip code) Registrant's telephone number, including area code: (510) 226-6874 ---------------------------- - -------------------------------------------------------------------------------- (Former Name or Former Address, if Changed Since Last Report) INFORMATION TO BE INCLUDED IN THE REPORT ITEM 5. OTHER EVENTS The following unaudited balance sheet information as of December 31, 1998 is being provided by the Registrant at the request of the Nasdaq Stock Market. HUMAN PHEROMONE SCIENCES, INC. Unaudited Balance Sheet Information December 31, 1998 December 31, 1998 ------------ Assets Current assets: Cash and cash equivalents $ 76,696 Accounts receivable, net of allowances of $677,735 2,051,574 Inventory 2,894,541 Other current assets 138,635 ------------ Total current assets 5,161,446 Property and equipment, net 58,596 ------------ $ 5,220,042 ============ Liabilities and Shareholders' equity Current liabilities: Accounts payable $ 691,674 Loan payable, bank 773,534 Other accrued expenses 1,345,204 ------------ Total current liabilities 2,810,412 Commitments -- Shareholders' equity: Convertible preferred stock, issuable in series, no par value, 10,000,000 shares authorized, 1,439,333 issued and outstanding 2,745,535 Common stock, no par value, 40,000,000 shares authorized, 10,289,488 shares issued and outstanding 17,667,024 Accumulated deficit (18,002,929) ------------ Total shareholders' equity 2,409,630 ------------ $ 5,220,042 ============ -2- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HUMAN PHEROMONE SCIENCES, INC. Date: January 28, 1999 By: /s/ William P. Horgan -------------------------------------------- William P. Horgan, Chief Executive Officer -3-